Efficacy and safety of SMET12 in combination with toripalimab and chemotherapy in advanced non-small-cell lung cancer patients tested positive for EGFR protein who are treatment-naïve or harbor acquired resistance to standard therapy: a phase 2, mult

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-01-08
DOI
https://doi.org/10.3389/fimmu.2025.1706961
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of SMET12 in combination with toripalimab and chemotherapy in advanced non-small-cell lung cancer patients tested positive for EGFR protein who are treatment-naïve or harbor acquired resistance to standard therapy: a phase 2, mult

Miaoxiu Li, Hui Xu, Haipo Wang, Lihong Weng et al.
Frontiers in Immunology
Cancer Immunotherapy and Biomarkers
article

Efficacy and safety of SMET12 in combination with toripalimab and chemotherapy in advanced non-small-cell lung cancer patients tested positive for EGFR protein who are treatment-naïve or harbor acquired resistance to standard therapy: a phase 2, mult

Miaoxiu Li, Hui Xu, Haipo Wang, Lihong Weng, Jinyan Zhang, Shanshan Chen, Dong Lin, Zhiyong He, Jinghui Lin, Qiang Wang, Qinying Liu
article en

Abstract

No abstract available for this paper.
Frontiers in ImmunologyVol. 16
Fujian Medical University (CN), Fujian Provincial Cancer Hospital (CN)
Good health and well-being
Openalex Percentile: Top 97%
Cancer Immunotherapy and Biomarkers
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.